Advanced search
Publication Cover
HIV Clinical Trials Volume 19, 2018 - Issue 6
Submit an article Journal homepage
877
Views
12
CrossRef citations to date
0
Altmetric
Brief Report

Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects

Amedeo F. Capetti1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4633-1035
ORCID Icon,
Giuseppe V. De SocioInfectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy; ORCID Iconhttp://orcid.org/0000-0001-8774-4843
ORCID Icon,
Maria V. Cossu1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy;
,
Gaetana SterrantinoDivision of Infectious Diseases, “Careggi” Hospital, Firenze, Italy;
,
Giovanni CenderelloDivision of Infectious Diseases, Ospedali Galliera, Genova, Italy;
,
Annamaria CattelanInfectious and Tropical Diseases, Azienda Ospedaliera-Universitaria di Padova, Padova, Italy;
,
Gian M. Baldin2nd Division of Infectious Diseases, Università Cattolica del Sacro Cuore, Roma, Italy; ORCID Iconhttp://orcid.org/0000-0003-4623-9976
ORCID Icon,
Alessandro SoriaClinic of Infectious Diseases, San Gerardo Hospital, ASST Monza, University of Milano-Bicocca, Milan, Italy;
,
Niccolò RiccardiInfectious Diseases Clinic, “San Martino” Hospital, Genova, Italy;
,
Fosca P. Niero1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy;
,
Benedetto M. CelesiaInfectious Diseases Unit, University of Catania, ARNAS (Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione) Garibaldi, Catania, Italy;
,
Giorgio Barbarini2nd Division of Infectious Diseases, “Policlinico San Matteo” Hospital, Pavia, Italy;
,
Stefano RusconiInfectious Diseases Unit, DIBIC Luigi Sacco, University of Milano, Milan, Italy;
&
Giuliano Rizzardini1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy; ;School of Clinical Medicine, Faculty of Health Sciences, Whitwaterstrand University, Johannesburg, South Africa
 show all
Pages 242-248 | Received 06 Aug 2018, Accepted 12 Nov 2018, Published online: 20 Mar 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Camilla Ingrid Hatleberg, Lene Ryom & Caroline Sabin. (2021) Cardiovascular risks associated with protease inhibitors for the treatment of HIV. Expert Opinion on Drug Safety 20:11, pages 1351-1366.
Read now

Articles from other publishers (11)

José R Santos, Pere Domingo, Joaquín Portilla, Félix Gutiérrez, Arkaitz Imaz, Helem Vilchez, Adrià Curran, Nieves Valcarce-Pardeiro, Antoni Payeras, Enrique Bernal, Marta Montero-Alonso, Miguel Yzusqui, Bonaventura Clotet, Sebastià Videla, José Moltó & Roger Paredes. (2023) A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases 10:11.
Crossref
Emmanuelle Papot, Richard Kaplan, Marco Vitoria & Mark N. Polizzotto. (2021) Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective. AIDS 35:Supplement 2, pages S153-S163.
Crossref
Eva Wolf, Christoph Boesecke, Annamaria Balogh, Helen Bidner, Christiane Cordes, Hans Heiken, Ivanka Krznaric, Tim Kümmerle, Hans-Jürgen Stellbrink, Jochen Schneider & Christoph D. Spinner. (2021) Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance. AIDS Research and Therapy 18:1.
Crossref
Daniele Armenia, Yagai Bouba, Roberta Gagliardini, Lavinia Fabeni, Vanni Borghi, Giulia Berno, Alessandra Vergori, Stefania Cicalini, Cristina Mussini, Andrea Antinori, Francesca Ceccherini‐Silberstein, Carlo Federico Perno & Maria Mercedes Santoro. (2021) Virological response and resistance profile in highly treatment‐experienced HIV‐1‐infected patients switching to dolutegravir plus boosted darunavir in clinical practice. HIV Medicine 22:6, pages 519-525.
Crossref
Annegret Pelchen-Matthews, Álvaro H. Borges, Joanne Reekie, Line D. Rasmussen, Lothar Wiese, Jonathan Weber, Christian Pradier, Olaf Degen, Roger Paredes, Luba Tau, Leo Flamholc, Magnus Gottfredsson, Justyna Kowalska, Elzbieta Jablonowska, Iwona Mozer-Lisewska, Roxana Radoi, Marta Vasylyev, Anastasiia Kuznetsova, Josip Begovac, Veronica Svedhem, Andrew Clark & Alessandro Cozzi-Lepri. (2021) Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes 87:2, pages 806-817.
Crossref
Marco Berruti, Niccolò Riccardi, Diana Canetti, Sergio Lo Caputo, Lucia Taramasso & Antonio Di Biagio. (2021) Injectable Antiretroviral Drugs: Back to the Future. Viruses 13:2, pages 228.
Crossref
Hélène Chaussade, Camille Tumiotto, Fabien Le Marec, Olivier Leleux, Lucile Lefèvre, Estibaliz Lazaro, Marie-Edith Lafon, Elsa Nyamankolly, Pierre Duffau, Didier Neau, Pantxika Bellecave & Fabrice Bonnet. (2020) A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort. Open Forum Infectious Diseases 7:12.
Crossref
Tongai G. Maponga, Anna L. McNaughton, Marije van Schalkwyk, Susan Hugo, Chikezie Nwankwo, Jantjie Taljaard, Jolynne Mokaya, David A. Smith, Cloete van Vuuren, Dominique Goedhals, Shiraaz Gabriel, Monique I. Andersson, Wolfgang Preiser, Christo van Rensburg & Philippa C. Matthews. (2020) Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort. Journal of Infection 81:1, pages 121-130.
Crossref
Nittaya Phanuphak & Roy M. Gulick. (2020) HIV treatment and prevention 2019. Current Opinion in HIV and AIDS 15:1, pages 4-12.
Crossref
Lucia Taramasso, Elena Ricci, Antonio Cascio, Laura Valsecchi, Barbara Menzaghi, Nicola Squillace, Paolo Maggi, Giuseppe Vittorio De Socio, Chiara Dentone, Giordano Madeddu, Giovanni F. Pellicanò, Leonardo Calza, Goffredo Angioni, Paolo Bonfanti & Antonio Di Biagio. (2019) Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA). AIDS Research and Therapy 16:1.
Crossref
Neha Sheth Pandit, Daniel B. Chastain, Andrea M. Pallotta, Melissa E. Badowski, Emily C. Huesgen & Sarah M. Michienzi. (2019) Simplifying ARV Therapy in the Setting of Resistance. Current Infectious Disease Reports 21:10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.